• VPH Tratamientos del HPV
  • Contact Us
  • | (54-11) 4381-2009, Buenos Aires, Argentina.
  • info@hpvmedicalcenter.com.ar
  • HPV - VPH
  • HPV

PRESS

Bill seeks more HPV coverage

Bill seeks more HPV coverage HPV treatment By Marissa Cumbers

New legislation proposed in a Michigan Senate committee would require health insurance providers to cover testing for human papillomavirus, or HPV.

Insurance providers would be required to cover the HPV test, which exposes a virus that is linked to cervical cancer, under a two-bill package sponsored by state Sen. Martha Scott, D-Highland Park.

“Women are dying before their time because they can’t have this test,” Scott said.
{ "@context": "http://schema.org/", "@type": "Product", "name": "Bill seeks more HPV coverage", "image": "https://www.tratamiento-del-hpv.com.ar/JUS/upload/files/images/hpv-cancer.gif", "brand": { "@type": "Thing", "name": "PRESS" }, "aggregateRating": { "@type": "AggregateRating", "ratingValue": "4.5", "reviewCount": "6" } } }

Public Health workshop enhances programing of 26th International Papillomavirus Conference

Public Health workshop enhances programing of 26th International Papillomavirus Conference HPV treatment MONTREAL, Mar. 2, 2010 (Canada NewsWire Group) -- /CNW Telbec/ -- Public health professionals are for the first time invited to the Public Health Workshop, a bilingual preconference that will be held July 3 to 4, 2010, at the Palais des congrès de Montréal, as a complement to the 26th International Papillomavirus Conference. The initiative, proposed jointly by the Public Health Agency of Canada and the Institut national de santé publique du Québec, will highlight the many public health issues connected with preventing human papillomavirus (HPV) and related diseases and cancers.

Dr. Marc Steben, Steering Committee co-chair, elaborates: "The Public Health Workshop will meet a real need for skills development. We are committed to making the training as interactive as possible, with a view to exchanging information and building on the lessons learned, in addition to the many solutions that have come from HPV-related experiences here and elsewhere."

HPV vaccine now available for boys

HPV vaccine now available for boys HPV treatment By QMI Agency

Last Updated: February 23, 2010 2:39pm
An HPV vaccine that protects women from most varieties of genital warts and cervical cancer, has been approved for use by boys and men in Canada.

The vaccine, Gardasil, has been approved for boys and men ages nine through 26, the same age range as its approval in girls and women. In 2007, the federal government announced $300 million in funding to deliver

HPV vaccine to prevent genital warts approved for males aged 9 to 26 in Canada

HPV vaccine to prevent genital warts approved for males aged 9 to 26 in Canada HPV treatment (CP) – 19 hours ago

TORONTO — The vaccine manufacturer Merck says Health Canada has approved Gardasil for the prevention of genital warts caused by HPV infection in boys and men aged nine to 26.

HPV, or human papillomavirus, is the most common sexually transmitted infection and can also cause anal cancer in men. Gardasil has already been approved for females aged nine to 26 in Canada to prevent cervical cancer and genital warts.

The vaccine is designed to prevent infection by four of the most common strains of the virus.

Free and reduced HPV vaccine

Free and reduced HPV vaccine HPV treatment By Myrriah Gossett

The Coastal Health District will offer women aged 19-26 the full Human Papillomavirus vaccine. The treatment was developed to help prevent cervical cancer caused by HPV.

The vaccine is given over a course of three doses. All three are required for the vaccine to be fully effective. The series, which normally cost upwards of $160 per dose, will only cost an administrative fee of $14. However, the Coastal Health District has said that they will not turn away those who cannot pay the fee.


Cervical cancer vaccine, conference offer women hope

Cervical cancer vaccine, conference offer women hope  HPV treatment
Tuesday, 02 March 2010 19:54 By Maya Prabhu

March could mark a turning point in the fight against cervical cancer in Uganda.  In the context of the increasing international availability of a new vaccine, government officials and NGOs involved in the struggle against cervical cancer will launch a strategic plan to combat the disease.

Prevention International: No Cervical Cancer brings care, training and equipment to clinics and hospitals in 8 countries, screening and treating poor women.
At the same time, Mulago Hospital, Makerere University, and the organisation PATH will begin joint research into new methods of screening for the illness. Efforts also include a pilot vaccination distribution programme currently taking place in two districts, which aims to gather sufficient information to make possible a future national vaccination strategy. Furthermore, the Uganda Cancer Institute will contribute to plans for a comprehensive national policy on cancer.

Screens, Vaccine for HPV Less Beneficial in Older Women

Screens, Vaccine for HPV Less Beneficial in Older Women HPV treatment Rate of new infections declined with age, study found

THURSDAY, Feb. 18 (HealthDay News) -- As women age, they receive fewer benefits from frequent screening for human papillomavirus (HPV) and vaccinations to prevent the virus, new research shows.

While infection with certain types of HPV can lead to cervical cancer, there is a vaccine that can help protect against many of these HPV infections.

However, this study of Costa Rican women, aged 18 to 97, concluded that the benefits of HPV vaccination and screening are low among women over the age of 41. The rate of newly detected cancer-causing HPV infections declined with age, ranging from 35 percent in women aged 18 to 25 to 13.5 percent in women aged 42 and older.

Merck Sharpe and Dohme publishes positive Gardasil trial data

Merck Sharpe and Dohme publishes positive Gardasil trial data HPV treatment Posted on 18/02/2010 in Pharmaceutical Company Product News

Merck Sharpe and Dohme has published new clinical trial data from a study of its human papillomavirus (HPV) treatment Gardasil, which it believes shows its efficacy for both males and females.

The pharmaceutical company conducted a phase III trial to gauge the effectiveness of the treatment in preventing infections and diseases related to the sexually-transmitted condition.

Merck s Study Show Gardasil Effective In anal diseases In Gays Update

Merck s Study Show Gardasil Effective In anal diseases In Gays Update HPV treatment 2/17/2010 3:22 PM  ET

(RTTNews) -  Wednesday, Merck & Co., Inc. (MRK: News ) said its phase 3 trial of Gardasil was efficacious in preventing anal diseases and anal cancer in gay men.


The drug was found to be 77.5% efficacious against anal intraepithelial neoplasia, associated with certain human papillomavirus or HPV types, in 16-to-26 year-old men who have sex with men.

Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping

Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping HPV treatment MONTE CARLO, Monaco, Feb. 18 /PRNewswire-FirstCall/ -- Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program. Thomas C. Wright Jr., M.D., of Columbia University presented the preliminary data on February 18 during the Genotyping session (Scientific Session 2) at the EUROGIN 2010 congress in Monaco.

"The findings to date from the ATHENA trial support the growing understanding that certain HPV genotypes are highly associated with the development of high-grade cervical intraepithelial neoplasia (CIN grade 2 or higher), a direct precursor to cervical cancer," said Dr. Wright.

ZAMBIA: Cervical cancer screening saves lives

ZAMBIA: Cervical cancer screening saves lives  HPV treatment JOHANNESBURG, 18 February 2010 (PlusNews) - Cervical cancer is a leading killer among women living with HIV, but a low-cost screening programme developed in Zambia is proving that simple techniques can go a long way in saving lives.

New research presented this week at the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco has shown that cervical cancer screening among HIV-positive women prevented one death for every 32 women screened.

Presented by Dr Groesbeck Parham of the University of Alabama at Birmingham, the research originated from a pilot study of about 6,600 HIV-positive women examined as part of the Cervical Cancer Prevention Programme in Zambia (CCPPZ), an ongoing low-cost screening project. More than half the women had abnormal results, and about 20 percent were diagnosed as having lesions at varying stages from pre-cancerous to advanced cancer.

Hybrid Capture vs, PCR screening of Cervical Human Papilloma Virus Infections, Cytological and Histological associations in 1270 women

Hybrid Capture vs, PCR screening of Cervical Human Papilloma Virus Infections, Cytological and Histological associations in 1270 women HPV treatment ObjectiveWe evaluated two molecular methods of HPV detection and their correlation with cytological and histological diagnosis in a large sample of Greek women.

Methods: All women with liquid-based cytology performed at a University Hospital between 2000 and 2003 were included. The Hybrid Capture 2 (HC2) kit and in house Polymerase Chain Reaction (PCR) were used for HPV DNA detection.

Cervical biopsy was performed for women with ASCUS+ cytology, HPV detection, or abnormal colposcopy. Positive (PLR) and negative (NLR) likelihood ratios were calculated for cytology and HPV molecular testing for the prediction of CIN2 and greater histology.

Cervical cancer: A preventable, treatable disease

Cervical cancer: A preventable, treatable disease HPV treatment By ThisDay Reporter
15th February 2010
Though cervical cancer is completely preventable, with screening exams and treatment, it continues to claim a considerable chunk of women population throughout the world. Considered the fifth most deadly cancer in women worldwide, cervical cancer affects about 16 per 100,000 women per year and kills about 9 per 100,000 per year, that is 800 women a day.

It remains unfortunate that about 83 per cent of the cases occur in developing countries, representing 15 per cent of female cancers. In Tanzania, cervical cancer ranks as the first most frequent cancer among women between 15 and 44 years of age.

There’s little time to lose

There’s little time to lose HPV treatment
Harmala Gupta, Hindustan Times
February 16, 2010

While in recent years, India has made tremendous economic progress, there is one area where it still lags woefully behind. I refer here to the incidence of cancer of the uterine-cervix or cervical cancer. In fact, we have the dubious distinction of outstripping any other country when it comes to the number of cases of this type of cancer (132,000 new cases are reported every year and around 74,000 women die annually of it).

Benefit of HPV Vaccination, Frequent Screening for Women Over 41 Is Likely to Be Low, Study Suggests

Benefit of HPV Vaccination, Frequent Screening for Women Over 41 Is Likely to Be Low, Study Suggests HPV treatment ScienceDaily (Feb. 15, 2010) — The overall potential benefits of human papillomavirus (HPV) vaccinations or frequent HPV screenings for women over the age of 41 are low, concludes a new study published online February 15 in the Journal of the National Cancer Institute. The study found that the rate of new infections preventable by vaccination declines with age. Furthermore, new infections among women at any age typically do not progress to cervical intraepithelial neoplasia grade 2 (CIN 2) or CIN 3, the precursors for cervical cancer.

This study was undertaken because researchers wanted to examine whether women's age and the duration of carcinogenic HPV infections influenced subsequent persistence of infection and risk of CIN 2 or worse disease.

Health Canada approves a second vaccine against HPV

Health Canada approves a second vaccine against HPV  HPV treatment André Picard Public Health Reporter

Globe and Mail Update
Published on Tuesday, Feb. 09, 2010 7:26PM EST
 
Last updated on Tuesday, Feb. 09, 2010 7:34PM EST
 
Canadian women who want to be immunized against HPV, a family of viruses that causes cervical cancer, now have a choice of two competing vaccines.

Study: HPV shot will slash cervical cancer rates

Study: HPV shot will slash cervical cancer rates HPV treatment
January 20, 2010 — 3:07pm ET | By Liz Jones

The number of women under the age of 30 diagnosed with cervical cancer will fall nearly two thirds by 2025 because they have received the HPV vaccine, according to a study published this week in the British Journal of Cancer.

U.K. researchers calculated the number of cancers that would be prevented by the vaccine, assuming 80 percent of girls received all three doses. Twelve and 13-year-old girls in the U.K. have been offered the vaccine since 2008, and government figures suggest that 78 percent of them had received all three doses.  

Health Canada Approves HPV Vaccine, Types 16 and 18

Health Canada Approves HPV Vaccine, Types 16 and 18 HPV treatment NEW YORK -- February 9, 2010 -- Health Canada has approved a new adjuvanted (AS04) human papillomavirus (HPV) vaccine (types 16 and 18 [Cervarix]) to protect girls and women aged 10 to 25 years against cervical cancer and abnormal and precancerous cervical lesions.

"In Canada, more than 1 woman dies every day from cervical cancer, a disease that is largely preventable," said Barbara Romanowski, MD, Division of Infectious Diseases, University of Alberta, Edmonton, Alberta. "Together with regular Pap tests, Cervarix reduces the risk of cervical cancer caused by HPV types 16 and 18, by 98%."

Life span anti-cancer jab queried

Life span anti-cancer jab queried HPV treatment A leading international vaccine expert is questioning whether a new anti-cancer jab lasts long enough to protect girls from cervical cancer.

Dr Diane Harper said Gardasil, the new vaccine against human papillomavirus (HPV), had not been proven to last more than five years.

Young girls, vaccinated at 12, may therefore not be exposed to the virus until after the vaccine had waned, she said.

HPV Vaccine For Boys

HPV Vaccine For Boys  HPV treatment There is another vaccination option for families. First we heard the HPV vaccine could protect girls from some strains of cervical cancer. Now, the same vaccine can protect boys from something else.
Reporter: Tracy Madden

Email Address: sixonline@wowt.com

There is another vaccination option for families. First we heard the HPV vaccine could protect girls from some strains of cervical cancer. Now, the same vaccine can protect boys from something else.

Study Does Not Support HPV Vaccine in Older Women

Study Does Not Support HPV Vaccine in Older Women HPV treatment
There is another vaccination option for families. First we heard the HPV vaccine could protect girls from some strains of cervical cancer. Now, the same vaccine can protect boys from something else.

Reporter: Tracy Madden
Email Address: sixonline@wowt.com

There is another vaccination option for families. First we heard the HPV vaccine could protect girls from some strains of cervical cancer. Now, the same vaccine can protect boys from something else.

Nurse Patty Wilderman feels so strongly about it, she had her two sons take part in a clinical trial here in Omaha.

HPV testing and vaccination less beneficial for older women

HPV testing and vaccination less beneficial for older women HPV treatment Updated: 2010-02-18 23:42:54 CST Category: Female Specific Tests
by Alex Schoenfeld

A recent study has found that older women benefit less from frequent human papillomavirus (HPV) vaccinations and screenings than do younger women. Additionally, researchers found that new infections in women of any age rarely progressed to cervical intraepithelial neoplasia grade 2 or 3, which are precursors for cervical cancer.

In the 7-year study, researchers from the Proyecto Epidemiologico Guanacaste in San Jose, Costa Rica screened more than 9,000 women of varying ages. They found that the rate of new HPV infections declined with age and that the benefits for vaccination were very low among women over the age of 41.

Low benefit for HPV vaccination, screening in older women

Low benefit for HPV vaccination, screening in older women HPV treatment
In women aged 34 years or older, the potential benefit of HPV vaccination or frequent HPV screening to prevent or detect new carcinogenic HPV infections was low. In addition, new infection in women of any age rarely progressed to cervical intraepithelial neoplasia grade 2 or 3.

Persistent HPV infections are the central cause of cervical cancer, and these infections often clear in younger women; however, there is less understanding about these infections in older women, according to researchers.

They conducted a longitudinal study of 9,466 women in Costa Rica grouped by age to determine whether women’s age and duration of carcinogenic HPV infections were linked to infection persistence and risk for CIN grade 2 or higher. There were 9,094 women in the follow-up.
{ "@context": "http://schema.org/", "@type": "Product", "name": "Low benefit for HPV vaccination, screening in older women", "image": "https://www.tratamiento-del-hpv.com.ar/JUS/upload/files/images/hpv-cancer.gif", "brand": { "@type": "Thing", "name": "PRESS" }, "aggregateRating": { "@type": "AggregateRating", "ratingValue": "4.5", "reviewCount": "6" } } }

HPV vaccine available at Coastal Georgia county health departments

HPV vaccine available at Coastal Georgia county health departments HPV treatment They're available at little or no cost for women who qualify.

By Teresa StepzinskiStory updated at 1:09 AM on Saturday, Feb. 13, 2010

BRUNSWICK, Ga. - Coastal Georgia county health departments are offering the Human Papillomavirus, HPV, vaccine available at little or no cost to women who meet criteria including those receiving Medicaid or Medicare.

The vaccine, commonly known as Gardasil, has been shown to be a safe and effective medicine to help prevent cervical cancer.

HPV Vaccine Reduces Rates of Genital Diseases in Young Women

HPV Vaccine Reduces Rates of Genital Diseases in Young Women HPV treatment Nick Mulcahy

Authors and Disclosures

February 11, 2010 — The quadrivalent vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (Gardasil, Merck & Co) results in statistically significant reductions of HPV-associated genital diseases, such as warts and cervical dysplasia, in young women who receive it, according to the final analysis of 2 randomized placebo-controlled efficacy trials.

The HPV vaccine also statistically significantly reduces Pap test abnormalities, procedures such as colposcopy, and definitive cervical therapy, compared with placebo, report the study authors, led by Nubia Muñoz, MD, from the National Institute of Cancer, in Bogota, Colombia.

HPV shot has health benefits for men, too

HPV shot has health benefits for men, too HPV treatment Health center began offering the HPV vaccine for males after approval in December

By Rachel Hatch News reporter


Published: Wednesday, January 27, 2010

The University Health Center has recommended the human papillomavirus (HPV) vaccine for women since the Food and Drug Administration approved it in 2006, but it’s now turning its attention toward males.

In December, the health center began allowing men to get the HPV vaccine, and recently, it has been encouraging more men to schedule appointments for the shots.

“We would have liked to make the vaccine available to men much earlier,” Interim Medical Director Jenny Soyke said. “The (Centers for Disease Control and Prevention) didn’t approve the vaccine until December, so now we can give it to them.”

New HPV vaccine approved

New HPV vaccine approved HPV treatment Published Thursday February 11th, 2010

FREDERICTON - Health Canada approved a new human papillomavirus (HPV) vaccine this week and the New Brunswick Department of Health will study it to see if it should change over its own supply.

Cervarix, a vaccine from pharmaceutical company GlaxoSmithKline Inc., has been given the green light by the federal health department and should be available in Canada by the end of the month. It is designed to protect against HPV, a sexually transmitted disease that can lead to cervical cancer.

Merck

Merck HPV treatment

HPV vaccine programme to be deferred to September

HPV vaccine programme to be deferred to September HPV treatment Cervical cancer vaccination will be available for girls already in first year and for those entering secondary school, writes MUIRIS HOUSTON

THE HPV vaccination programme against cervical cancer is now expected to start in September, targeting both first and second year girls in its initial stages, the Health Service Executive’s leading vaccination expert has indicated.

In a memo sent to Prof Brendan Drumm and other senior HSE managers and seen by The Irish Times, Dr Kevin Kelleher, assistant national director of population health, has recommended the option of vaccinating girls who are now in first year at secondary school as well as those who will be in first year by September.

Dr Kelleher said this option offers some economies of scale and will allow more time to complete discussions with key stakeholders such as school principals and management boards.

HIV Treatment Might Increase Clearance of HPV Infection in Women

HIV Treatment Might Increase Clearance of HPV Infection in Women HPV treatment Women living with HIV who regularly take antiretroviral (ARV) therapy may be more likely to clear human papillomavirus (HPV) and cervical lesions than women who don’t consistently take their meds, according to a study published in the March 1 issue of The Journal of Infectious Diseases.

Researchers have long known that HPV infection causes cervical lesions, also known as squamous intraepithelial lesions (SIL), and cervical cancer. It is also well known that rates of HPV infection, SIL and cervical cancer are higher in HIV-positive women than in the general population. What has been less clear is whether ARV therapy can reduce the prevalence of HPV infection and, with it, the risk of HPV-related diseases.

Study Does Not Support HPV Vaccine in Older Women

Study Does Not Support HPV Vaccine in Older Women HPV treatment By Janis C. Kelly, Medscape.com

Findings from a natural-history study of human papillomavirus (HPV) have led the investigators to conclude that the "potential benefit" of HPV vaccination in older women (≥42 years) is "low."

The research team, led by Ana Cecilia Rodríguez, MD, from the Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, in San José, Costa Rica, found that the rate of new HPV infections declines with age and that new infections usually do not progress to grade 2 or 3 cervical intraepithelial neoplasia (CIN) in older women.

The investigators found that infections at baseline were more likely to persist in older than in younger women (P < .01 for a comparison of 8 groups). Furthermore, most of the grade 2 or worse CIN disease that was detected during follow-up (66 of 85 cases) was associated with infections already present at baseline.

Cancer-thwarting lifestyles

Cancer-thwarting lifestyles HPV treatment
Cancer has been the No. 1 cause of death for Japanese since 1981, accounting for one-third of Japanese deaths. One's lifestyle is closely related to the contraction of cancer and one can avoid developing cancer to a large extent by changing one's lifestyle. Thus education can play an important role. Since many types of cancer develop slowly over many years, teaching children about the risk of cancer and the importance of having a healthy lifestyle will go a long way toward reducing cancer.


A report by researchers from the Geneva-based International Union Against Cancer (UICC) says that about 40 percent of cancers can be prevented by adopting a healthy lifestyle. Every year, Feb. 4 is marked as World Cancer Day, led by UICC and its member organizations in 86 nations with the support of the World Health Organization. This year UICC started a campaign "Cancers can be prevented too." WHO estimates that the number of global cancer deaths will increase 45 percent from 2007 to 11.5 million by 2030, up from 7.9 million deaths at present.

Dolphins Health Shed Light on Human and Ocean Health

Dolphins  Health Shed Light on Human and Ocean Health HPV treatment
ScienceDaily (Feb. 22, 2010) — A panel of governmental, academic and non-profit scientists speaking at the annual meeting of the American Association for the Advancement of Science (AAAS) unveiled research suggesting that diseases found in dolphins are similar to human diseases and can provide clues into how human health might be affected by exposure to contaminated coastal water or seafood.

"Dolphins and humans are both mammals, and their diet includes much of the same seafood that we consume. Unlike us, however, they are exposed to potential ocean health threats such as toxic algae or poor water quality 24 hours a day," said Carolyn Sotka of the NOAA Oceans and Human Health Initiative and lead organizer of the session. "Our ecological and physiological similarities make dolphins an important 'sentinel species' to not only warn us of health risks, but also provide insight into how our health can benefit from new medical discoveries."

Life span of anti-cancer jab queried

Life span of anti-cancer jab queried HPV treatment
By HELEN MURDOCH- The Press

A leading international vaccine expert is questioning whether a new anti-cancer jab lasts long enough to protect girls from cervical cancer.

Dr Diane Harper said Gardasil, the new vaccine against human papillomavirus (HPV), had not been proven to last more than five years.

Young girls, vaccinated at 12, may therefore not be exposed to the virus until after the vaccine had waned, she said.

Harper, a principal investigator for clinical trials of Gardasil and Cervarix, is a professor and vice-chair of research at the University of Missouri-Kansas City School of Medicine in the US.

Stop the cancer in its track

Stop the cancer in its track  HPV treatment DR. SHOBHA S. KRISHNAN

Cervical cancer is preventable and a massive awareness programme is needed to send this message home, especially in rural India.  

Saving women's lives by fighting cervical cancer has become a high priority in the global health agenda.

Photo: K. Pichumani
 
More awareness: Need innovative methods to spread information.

Gardasil approved for males

Gardasil approved for males HPV treatment Last Updated: Tuesday, February 23, 2010 | 7:34 PM ET
CBC News
Gardasil, a vaccine against human papilloma virus (HPV), has been approved as a treatment to prevent genital warts in males aged nine to 26 in Canada, the vaccine's manufacturer said Tuesday.

Health Canada approved Gardasil to prevent infection caused by human papilloma virus Types six, 11, 16, and 18 and genital warts caused by HPV types six and 11.

HPV vaccine approved for men

HPV vaccine approved for men HPV treatment Canwest News ServiceFebruary 24, 2010 3:02 AM  Health Canada has approved the use of a vaccine for boys and young men to protect them against the human papilloma virus and genital warts, pharmaceutical company Merck Frosst announced Tuesday.

The vaccine, Gardasil, was first approved by Health Canada in July 2006 for females between ages nine and 26, the same age group targeted for males. HPV is the most common sexually transmitted infection in Canada. More than 40,000 new cases are estimated annually.

HPV infects majority of young adults

HPV infects majority of young adults HPV treatment New research shows startling statistics on sexually transmitted HPV among young adults.
 
The study, conducted by a team of experts from McGill University and the University of Montreal, reveals that a startling 56 percent of young people contract human papillomavirus (HPV) early in their intimate encounters. Valerie Huber, executive director of the National Abstinence Education Association (NAEA), tells OneNewsNow the study needs to be taken seriously because some women develop a form of cervical cancer and because the highly touted drug Gardasil® is not a fail-safe vaccine.
 

Boys now recommended to get HPV vaccine

Boys now recommended to get HPV vaccine HPV treatment Half of the sexually active men and women in the United States will get the human papillomavirus (HPV) sometime in their lifetime. While many people will never know that they have HPV, the genital warts caused by the sexually transmitted infection can lead to several forms of cancer, including cervical, vulvar, vaginal, anal and penile cancer.
Initially approved for girls to help prevent cervical cancer, which kills 4,000 women in the United States annually, a vaccine developed to protect against HPV infections is now being recommended for boys age 9 to 18 years old, under new guidelines issued earlier this month by the American Academy of Pediatrics, the U.S. Centers for Disease Control and Prevention and the American Academy of Family Physicians.
The three-dose HPV vaccine Gardasil, which is manufactured by Merck, protects against four strains of the human papillomavirus (HPV), including two that cause 70 percent of cervical cancer cases.

Body and Mind: A Forum on Health

Body and Mind: A Forum on Health HPV treatment Cervical Cancer: A Preventable Disease
Hello readers!

I'm willing to bet that very few of you know that January is Cervical Cancer Awareness Month! I know I didn't. This changed when I was kindly invited to interview two local experts in the diagnosis and treatment of this disorder, as well as a patient that actually has it. What follows is the first in a series of articles focusing on cervical cancer from both a medical and patient perspective.

Cervical Cancer and HPV

The human papilloma virus (HPV) has recently been shown to be the most important risk factor for cervical cancer (a risk factor is something that increases one's risk of getting a particular disorder). There are other risk factors such as smoking, immunosuppression (reduced immune function), multiple full-term pregnancies, oral contraceptive use, and others; however, these are beyond the scope of the present article, whose purpose is to focus on the single most important risk factor, the HPV virus.

The HPV virus is virtually ubiquitous in the population; if you have ever had unprotected sex, then the chances are great that you have had (or currently do have) the virus. The good news is that most peoples' immune systems manage to clear the virus from their bodies naturally. However, in some individuals this does not occur, and the virus persists. In some of those instances, cervical cancer may develop.

Don’t let HPV put damper on sex life

Don’t let HPV put damper on sex life HPV treatment By Nicolette Pawlowski
Tuesday, February 9, 2010 10:46 p.m.

Hump Day,


My girlfriend just came back from the doctor. She says she has HPV and that I probably gave it to her (I was her first). I don’t have any symptoms. How do I check if I have HPV? Her doctor also told her to call other people I’ve slept with to get checked out as well. How the heck do I go about doing THAT?

Just a Crappy Situation

Dear JACS,
{ "@context": "http://schema.org/", "@type": "Product", "name": "Don’t let HPV put damper on sex life", "image": "https://www.tratamiento-del-hpv.com.ar/JUS/upload/files/images/hpv-cancer.gif", "brand": { "@type": "Thing", "name": "PRESS" }, "aggregateRating": { "@type": "AggregateRating", "ratingValue": "4.5", "reviewCount": "6" } } }

Free HPV vaccine available

Free HPV vaccine available HPV treatment Posted: Feb 12, 2010 12:50 PM
Updated: Feb 15, 2010 2:33 PM

GLYNN COUNTY, GA (WTOC) - The Human Papillomavirus (HPV) causes cervical cancer and is found in 8 out of 10 women.

The vaccine, Gardasil, is normally $160 per dose; however, the Coastal Health District will be offering the vaccine free of charge to non-pregnant women between 19 and 26 years of age through September of this year.
{ "@context": "http://schema.org/", "@type": "Product", "name": "Free HPV vaccine available", "image": "https://www.tratamiento-del-hpv.com.ar/JUS/upload/files/images/hpv-cancer.gif", "brand": { "@type": "Thing", "name": "PRESS" }, "aggregateRating": { "@type": "AggregateRating", "ratingValue": "4.5", "reviewCount": "6" } } }

Brace against cervical cancer

Brace against cervical cancer HPV treatment by Arun on February 3, 2010

Cancer of the cervix, the lower part of the uterus that connects the womb and the vagina, is the most common cancer affecting women in India. Nearly 200 women die everyday due to cervical cancer in the country. Worldwide, cervical cancer accounts for 15 per cent of all cancers in women, 80 per cent of these occurring in developing countries.

In the past, as a medical student, I remember that we saw at least one patient suffering from cervical cancer per outpatient day in a government hospital, usually with the cancer having spread so much that we could not really help her. But today, with Pap Smears being routinely done we hardly see any invasive cancers. A Pap test or Pap Smear is a simple test by which we take a smear from the cervix and look at it microscopically for abnormal cells.

Women s cancers preventable, but screening must

Women s cancers preventable, but screening must HPV treatment LUDHIANA: With cancers of the breast and cervical most prevalent ones among women living in cities, doctors say there is a dire need to spread awareness about them on a war footing, especially since these are preventable. This comes soon after experts recommended that cancers should be notified as this would enable the authorities to get a true picture of their spread.

Exhorting people to come forward for screening, the president of obstetrics and gynaecology society, Veena Jain, said women's cancers could be prevented. Jain said the society had decided to work on the theme — cancer can be prevented too — adding, of all cancers, the gynaecological ones could be prevented and cured.

All About The Cervical Cancer Vaccine

All About The Cervical Cancer Vaccine HPV treatment Written By: snigdha on February 3, 2010  0

Cervical cancer is the second most common malignancy among women worldwide, with about 500,000 cases a year. In developing countries it is the main cause of cancer deaths in women, and around 250,000 women die each year because of it. In the United States , cervical cancer strikes about 10,000 women a year and causes nearly 4,000 deaths. This steep rise in number of cervical cancer cases has led to governments promoting cervical cancer jabs in an attempt to prevent the spread of this cancer. In UK alone, more than a million girls are being offered the jab to protect them from the cancer-causing virus.

Cervical Cancer Kills A Woman Every Two Minutes

Cervical Cancer Kills A Woman Every Two Minutes HPV treatment Cervical cancer has been named as the leading form of cancer in women in Africa followed by breast cancer, killing one woman every two minutes.

Also, while cervical cancer accounts for 288,000 deaths per year worldwide, approximately 80 percent of death occurs in developing countries, where with only weak or non-existent cervical cancer screening and treatment programmes, it is the leading cause of death in women.

This was disclosed by Dr Benjamin Kumbour, the Minister of Health, at the inauguration of a Local Organising Committee (LOC) on “Stop Cervical Cancer and Breast Cancer” in Africa Conference to be hosted in Accra in July.

Times workshop on cervical cancer

Times workshop on cervical cancer HPV treatment NEW DELHI: Cervical cancer claims almost half a million women worldwide. In 99.7% of all affected women, it results from a history of persistent infection by a family of more than 100-related viruses called human papillomavirus (HPV). As many as 80% of all sexually-active women have a risk of infection. To address this problem which is the most common cancer to affect women in India, Times Foundation has organized a Wellness workshop on the disease in association with Super Religare Laboratories and Ahlon International School on Friday.

23 students HPV-positive in 2009

23 students HPV-positive in 2009 HPV treatment By Tierney SmithsonIssue date: 1/29/10 Section: News

Every January, SRU participates in Cervical Health Awareness Month, an entire month devoted to providing information on human papilomavirus and cervical cancer.

Because most cases of HPV are seen in ages 18-24, SRU's McClachlan Student Health Center participates in this event by setting up informational tables providing insight on cervical health, said Jessica Kaak, peer educator for Healthy Outreach through Peer Education.

Appleton woman helps puts spotlight on cervical cancer with Evening of Hope fundraiser

Appleton woman helps puts spotlight on cervical cancer with Evening of Hope fundraiser HPV treatment
Most people don't want to talk about cervical cancer. But Appleton's Kellie Delveaux has made it her life's mission.
Delveaux is co-founder of SAS Cervical Cancer Foundation, founded in memory of her friend Sybil Ann Seehawer, who was 31 when she died of cervical cancer in 2008. Delveaux was her caregiver.
The Appleton-based foundation supports women in Wisconsin with daily living expenses while they are undergoing treatment for cervical cancer, provides educational resources and raises awareness for women's health issues.
"It makes it so what happened to (Sybil) wasn't just a tragedy and forgotten," said Delveaux, one of 40 women chosen to participate last month in a congressional briefing at the Rayburn House Office Building on Capitol Hill and a day of lobbying under the auspices of Tamika & Friends, a Washington D.C.-based nonprofit organization also dedicated to raising awareness about cervical cancer.
"We just jumped on that bandwagon pretty fast," said Delveaux, who early on reached out to other cervical cancer foundations such as Tamika & Friends, run by cervical cancer survivor Tamika Felder, and Love, Kristen, an Indiana nonprofit run by Kirk and Brenda Forbes, who lost their 23-year-old daughter, Kristen, to cervical cancer.

UA Center, Institute Offering HPV Education Forum

UA Center, Institute Offering HPV Education Forum  HPV treatment Several UA centers have come together to offer a free public forum about human papillomavirus and the vaccine.

By University Communications January 26, 2010

Human papillomavirus infections are the most common sexually transmitted infections in the United States and, to inform the pubilc about the disease and ways to prevent it, several University of Arizona centers are sponsoring an education forum.  

The HPV Educational Forum 2010 is being presented by the Women’s Studies Advisory Council, Southwest Institute for Research on Women and the National Center of Excellence in Women’s Health through a partnership with the Marana Health Center.

New York Bills Would Mandate HPV Vaccines Without Parents Consent

New York Bills Would Mandate HPV Vaccines Without Parents  Consent HPV treatment
Two bills in the New York State legislature would, if passed, allow healthcare practitioners to vaccinate children under 18 against HPV without their parent’s consent. The bills would require the vaccinations before children could attend school, leading to the interesting potential scenario of schools vaccinating kids without their parents’ consent simply because the child wants to stay in school.


Even without the inevitable controversy over whether under-18s should be able to get preventive care from their doctors without their parents hearing the details of their sex lives, the bills read like full-employment acts for Merck (MRK)’s Gardasil and GlaxoSmithKline (GSK)’s Cervarix.

Senate bill No. S04779 is:

“AN ACT to amend the public health law, in relation to providing  medical care to minors for sexually transmitted diseases without a parent’s or guardian’s consent.”

Cervical Cancer: What Every Woman Needs To Know

Cervical Cancer: What Every Woman Needs To Know HPV treatment Cervical cancer starts when cells on the surface of your cervix acquire abnormal changes and begin to grow out of proportion,forming a mass in your cervix.THE CERVIX IS THE LOWER PART OF THE WOMB(UTERUS )often called the neck of the womb and links the womb to the vagina.

Cervical cancer is divided into early and advanced stages.In early cervical cancer the abnormal cells are still confined to the cervix.In advanced cancer the abnormal cells spread beyond the cervix and may involve the vagina,uterus,bladder,rectum,lungs and brain.Whilst about 95% of EARLY CERVICAL CANCER IS CURABLE,ADVANCED CANCER IS NOT AND EVENTUALLY LEADS TO DEATH.